# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-065464
Filing Date
2021-12-15
Accepted
2021-12-15 16:31:05
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2021_citiuspharma.htm iXBRL | 10-K | 1094016
2 | FORM OF NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AWARD AGREEMENT | f10k2021ex10-29_citiuspharma.htm | EX-10.29 | 58596
3 | ASSET PURCHASE AGREEMENT | f10k2021ex10-30_citiuspharma.htm | EX-10.30 | 336304
4 | AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT | f10k2021ex10-31_citiuspharma.htm | EX-10.31 | 605178
5 | AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGR | f10k2021ex10-32_citiuspharma.htm | EX-10.32 | 14779
6 | AMENDMENT NO. 2 TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATI | f10k2021ex10-33_citiuspharma.htm | EX-10.33 | 44505
7 | SUBSIDIARIES | f10k2021ex-21_citiuspharma.htm | EX-21 | 2881
8 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2021ex23-1_citiuspharma.htm | EX-23.1 | 2031
9 | CERTIFICATION | f10k2021ex31-1_citiuspharma.htm | EX-31.1 | 10806
10 | CERTIFICATION | f10k2021ex31-2_citiuspharma.htm | EX-31.2 | 18845
11 | CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN | f10k2021ex32-1_citiuspharma.htm | EX-32.1 | 5695
| Complete submission text file | 0001213900-21-065464.txt |  | 5999176

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | ctxr-20210930.xsd | EX-101.SCH | 58325
13 | XBRL CALCULATION FILE | ctxr-20210930_cal.xml | EX-101.CAL | 34453
14 | XBRL DEFINITION FILE | ctxr-20210930_def.xml | EX-101.DEF | 216330
15 | XBRL LABEL FILE | ctxr-20210930_lab.xml | EX-101.LAB | 459406
16 | XBRL PRESENTATION FILE | ctxr-20210930_pre.xml | EX-101.PRE | 230297
17 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2021_citiuspharma_htm.xml | XML | 391185

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 211494551
SIC: 2834 Pharmaceutical Preparations